The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
Clinical trial NCT03062059 · UNKNOWN
Trial details
- NCT number
- NCT03062059
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2022-12-31
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.